Trial | NCT00135070  Report issue

Title

Hospital In-Patient Insulin Study
A Randomised Study Comparing Continuous Intravenous Insulin Infusion With Subcutaneous Insulin Analogues in Hospitalised Patients With Type II Diabetes and Hyperglycaemia

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Terminated

  • Study Participants

    41
Hyperglycaemia has been shown to increase morbidity and mortality in patients with critical illness, myocardial infarction and stroke. This study aims to look at patients with hyperglycaemia and reduce their blood sugar levels using differing combinations of subcutaneous and intravenous insulin.
This is a randomised trial involving patients with type II diabetes who are brought into the hospital with a problem other than a diabetic emergency. Patients will be included, who have a blood sugar > than 17mmols. They will be randomised to one of two groups and either given intravenous or subcutaneous insulin. Outcome measures are length of stay, glucose control and comparison of the two regimens. Cost implications will also be analysed.
Study Started
Jul 31
2005
Study Completion
Jun 30
2006
Last Update
May 01
2007
Estimate

Drug Detemir

Criteria 

Inclusion Criteria:

Type II diabetes
Blood glucose > 17mmols

Exclusion Criteria:

Type I diabetes
Hyperosmolar non-ketotic coma (HONK)
Diabetic ketoacidosis (DKA)
Myocardial infarction (MI)
Vomiting
No Results Posted